Atidarsagene autotemcel, offered under the model title Libmeldy among Other people, is a gene therapy cure for metachromatic leukodystrophy designed by Orchard Therapeutics. The cure is administered through just one infusion,five following a conditioning regimen of substantial-dose chemotherapy, and it makes use of a individual’s genetically modified hematopoietic (blood) stem https://libmeldy39493.designi1.com/56838965/not-known-details-about-libmeldy